AU6264596A - Diagnosis, prognosis and monitoring of angiogenesis dependen t diseases - Google Patents

Diagnosis, prognosis and monitoring of angiogenesis dependen t diseases

Info

Publication number
AU6264596A
AU6264596A AU62645/96A AU6264596A AU6264596A AU 6264596 A AU6264596 A AU 6264596A AU 62645/96 A AU62645/96 A AU 62645/96A AU 6264596 A AU6264596 A AU 6264596A AU 6264596 A AU6264596 A AU 6264596A
Authority
AU
Australia
Prior art keywords
dependen
prognosis
angiogenesis
diagnosis
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU62645/96A
Inventor
Moses Judah Folkman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Medical Center Corp
Original Assignee
Childrens Medical Center Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Medical Center Corp filed Critical Childrens Medical Center Corp
Publication of AU6264596A publication Critical patent/AU6264596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/475—Assays involving growth factors
    • G01N2333/50—Fibroblast growth factors [FGF]
    • G01N2333/503—Fibroblast growth factors [FGF] basic FGF [bFGF]
AU62645/96A 1995-06-07 1996-06-07 Diagnosis, prognosis and monitoring of angiogenesis dependen t diseases Abandoned AU6264596A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48262395A 1995-06-07 1995-06-07
US482623 1995-06-07
PCT/US1996/009660 WO1996041194A1 (en) 1995-06-07 1996-06-07 Diagnosis, prognosis and monitoring of angiogenesis dependent diseases

Publications (1)

Publication Number Publication Date
AU6264596A true AU6264596A (en) 1996-12-30

Family

ID=23916782

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62645/96A Abandoned AU6264596A (en) 1995-06-07 1996-06-07 Diagnosis, prognosis and monitoring of angiogenesis dependen t diseases

Country Status (2)

Country Link
AU (1) AU6264596A (en)
WO (1) WO1996041194A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6358735B1 (en) 1995-06-30 2002-03-19 University Of Kansas Medical Center Method for inhibiting angiogenesis and tumors with the isolated NC1 α3 chain monomer of type IV collagen
US6440729B1 (en) 1995-06-30 2002-08-27 University Of Kansas Medical Center Treating angiogenesis-mediated diseases with the α2 monomer of type IV collagen
US5942385A (en) * 1996-03-21 1999-08-24 Sugen, Inc. Method for molecular diagnosis of tumor angiogenesis and metastasis
US5801012A (en) 1996-09-17 1998-09-01 Northwestern University Methods and compositions for generating angiostatin
ES2339196T3 (en) 1997-07-18 2010-05-17 Novo Nordisk Health Care Ag USE OF FVIIA OR FVIIAI FOR THE TREATMENT OF ENDOTELIAL DYSFUNCTION AND FOR THE INHIBITION OF ANGIOGENESIS, RESPECTIVELY.
WO2001011371A2 (en) * 1999-08-07 2001-02-15 Ali Said Assad Taha Diagnosis of inflammation measuring il-8 in urine
WO2006119292A2 (en) 2005-04-29 2006-11-09 Henkin, Robert Methods for detection of biological substances
US8506934B2 (en) 2005-04-29 2013-08-13 Robert I. Henkin Methods for detection of biological substances
CA2620964A1 (en) * 2005-09-14 2007-03-22 The Regents Of The University Of California Salivary protein and rna for breast cancer detection
WO2008095136A2 (en) 2007-01-31 2008-08-07 Henkin Robert I Methods for detection of biological substances
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
EP2399131B1 (en) * 2009-02-20 2014-08-27 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Method for the diagnosis of age-associated vascular disorders
CN106233141B (en) 2014-02-18 2018-08-21 罗伯特·I·汉金 The method and composition of loss and/or distortion for the diagnosing and treating sense of taste or smell

Also Published As

Publication number Publication date
WO1996041194A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
AUPM537994A0 (en) Early detection of glaucoma
AU5356996A (en) Health monitoring system
AU7385396A (en) Continuous monitoring of diabetes-related blood constituents
AU3660795A (en) Oxazolidinedione derivatives, their production and use
AU6124296A (en) Novel dolastatin derivatives, their preparation and use
AU6264596A (en) Diagnosis, prognosis and monitoring of angiogenesis dependen t diseases
AU4929896A (en) Multiple cuff blood pressure system
AU6604196A (en) Stethoscope shield
AU4329396A (en) Use of 3,4-diphenylchromans
AU2513997A (en) Diagnosis and monitoring of neurological disease
AU6336096A (en) Non-invasive uterine activity sensor
AU2667197A (en) Stabilized preparations of human troponins and modifications thereof, diagnostic assay methods and assay kits
AU4079296A (en) Structure of seat covers which is capable of withstanding lacerations, and method for the manufacture thereof
AU6591596A (en) Gene encoding the human homolog of mad2
AU4418096A (en) Diagnosis of pancreatitis
AU7560296A (en) Medical installation
AU1181897A (en) Medical use of proteases
AU4670696A (en) Diagnosis of toxicoinfectious clostridiosis
AU5509796A (en) Tissue entrapment
AU1209497A (en) Oxazole derivatives, their production and use
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
AU7383896A (en) Improved blood pressure monitoring cuff
AU4716196A (en) Method of producing oxazolidinones, the use thereof and novel oxazolidinones
AU1208697A (en) Diagnostic drugs
AU7142196A (en) Determination and monitoring of bladder cancer